Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01076_DB01149_nanopub.RAxBS7nCboZJyUAkHxusBwJzv3HTXtt6N0wn6LgN5q82E#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01076_DB01149 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01076_DB01149 label "DDI between Atorvastatin and Nefazodone - Nefazodone, a strong CYP3A4 inhibitor, may increase the serum concentration of atorvastatin by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of atorvastatin if nefazodone is initiated, discontinued or dose changed. [drugbank_resource:DB01076_DB01149]" assertion.
- drugbank_resource:DB01076_DB01149 identifier "drugbank_resource:DB01076_DB01149" assertion.
- drugbank_resource:DB01076_DB01149 title "DDI between Atorvastatin and Nefazodone - Nefazodone, a strong CYP3A4 inhibitor, may increase the serum concentration of atorvastatin by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of atorvastatin if nefazodone is initiated, discontinued or dose changed." assertion.
- drugbank:DB01149 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01076_DB01149 assertion.
- drugbank:DB01076 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01076_DB01149 assertion.